Think JPM seemed slow this year? You're not alone—and here's why
admin 16th January 2020 Uncategorised 0For many attendees, this year’s J.P. Morgan Healthcare Conference didn’t seem to live up to its trademark frenetic energy. Last year, Bristol-Myers’ $74 billion Celgene deal announcement—which happened just days before JPM—set the biopharma world abuzz, and Lilly kept the ball rolling with its $8 billion Loxo pact on Day 1 of the meeting. But this year? Crickets.
More: Think JPM seemed slow this year? You're not alone—and here's why
Source: fierce